A Study of Reccurence of Pterygium in Maharashtra


Authors : Dr. Sarosh Omar Syed; Dr. Kashinath Choudhary; Dr. Archana Vare

Volume/Issue : Volume 9 - 2024, Issue 5 - May

Google Scholar : https://tinyurl.com/49px6et4

Scribd : https://tinyurl.com/554kcvd9

DOI : https://doi.org/10.38124/ijisrt/IJISRT24MAY692

Abstract : Background This study investigated the recurrence rates of primary pterygium following different surgical approaches, including conjunctival autografting alone, conjunctival autografting with intraoperative mitomycin C, and amniotic membrane grafting.  Methods In a retrospective cohort study of primary pterygium conducted from October 2022 to October 2024, 560 patients with an average age of 53.3 ± 14.1 years were included, with 94 cases undergoing surgery. Pterygium involving the cornea was present in 55% of cases. The overall recurrence rate for the three procedures was 17%, with an average time to recurrence of 14.2 ± 11.9 months, and 37% of recurrences occurred after the first year. Dry eye disease was the only significant risk factor for recurrence in both univariate (p = 0.021) and multivariate analysis (p = 0.026). The recurrence rates following conjunctival autografting with and without mitomycin C were 15.6% and 15.8%, respectively, while the rate following amniotic membrane grafting was twofold higher at 27% (OR= 2.02) compared to conjunctival autografting (15.8%).  Conclusions Dry eye disease was identified as the sole factor associated with pterygium recurrence in this study. The finding highlights the significance of extended post- operative monitoring, as over one-third of recurrences were detected after the first year. The slightly elevated recurrence rate following conjunctival grafting in our study, compared to existing literature, can be attributed to variances in study locations, demographics, and follow- up durations.

Keywords : Pterygium, Conjunctival, Amniotic.

References :

  1. Coster D. Pterygium–an ophthalmic enigma. Br J Ophthalmol. 1995;79(4): 304–5.
  2. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92(11):1461–70.
  3. Balci M, Sahin S, Mutlu FM, Yağci R, Karanci P, Yildiz M. Investigation of oxidative stress in pterygium tissue. Mol Vis. 2011;17:443–7.
  4. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol. 2010;94(7):815–20.
  5. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open. 2013;3(11):e003787.
  6. Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 2007;18(4):308–13.
  7. Rezvan F, Khabazkhoob M, Hooshmand E, Yekta A, Saatchi M, Hashemi H. Prevalence and risk factors of pterygium: a systematic review and metaanalysis. Surv Ophthalmol. 2018;63(5):719–35.
  8. Alqahtani J. The prevalence of pterygium in Al-Khobar: A hospital-based study. Journal of Family and Community Medicine. 2013;20(3):159–61.
  9. Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol. 1995;120(2):151–60.
  10. Qin XJ, Chen HM, Guo L, Guo YY. Low-dose strontium-90 irradiation is effective in preventing the recurrence of pterygia: a ten-year study. PLoS One. 2012;7(8):e43500.
  11. Nassiri N, Farahangiz S, Rahnavardi M, Rahmani L, Nassiri N. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg. 2008; 34(6):902–8.
  12. Avisar R, Avisar I, Bahar I, Weinberger D. Effect of mitomycin C in pterygium surgery on corneal endothelium. Cornea. 2008;27(5):559–61.
  13. Lindquist TP, Lee WB. Mitomycin C-associated scleral stromalysis after pterygium surgery. Cornea. 2015;34(4):398–401.
  14. Campagna G, Adams M, Wang L, Khandelwal S, Al-Mohtaseb Z. Comparison of Pterygium Recurrence Rates Among Different Races and Ethnicities After Primary Pterygium Excision by Surgeons in Training. Cornea. 2018;37(2):199–204.
  15. Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992;99(7):1056–61.
  16. Modenese A, Gobba F. Occupational Exposure to Solar Radiation at Different Latitudes and Pterygium: A Systematic Review of the Last 10 Years of Scientific Literature. Int J Environ Res Public Health. 2017;15(1):37
  17. Coroneo MT. Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol. 1993;77(11):734–9.
  18. Yanoff M, Duker J. Ophthalmology. 5th. Philadelphia:Elsevier; 2018.
  19. Elliot RH. Tropical Ophthalmology. London: Oxford Medical Publications; 1920.
  20. Wang Y, Shan G, Gan L, Qian Y, Chen T, Wang H, et al. Prevalence and associated factors for pterygium in Han and Mongolian adults: a crosssectional study in inner Mongolian, China. BMC Ophthalmol. 2020;20(1):45.
  21. Pyo EY, Mun GH, Yoon KC. The prevalence and risk factors for pterygium in South Korea: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010. Epidemiol Health. 2016;38:e2016015.
  22. Minami K, Tokunaga T, Okamoto K, Miyata K, Oshika T. Influence of pterygium size on corneal higher-order aberration evaluated using anteriorsegment optical coherence tomography. BMC Ophthalmol. 2018;18(1):1
  23. Mohammad-Salih PA, Sharif AF. Analysis of pterygium size and induced corneal astigmatism. Cornea. 2008;27(4):434–8.
  24. Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115(10): 1235–40.
  25. Aidenloo NS, Motarjemizadeh Q, Heidarpanah M. Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, singlecentre investigation. Jpn J Ophthalmol. 2018;62(3):349–56.
  26. Huerva V, March A, Martinez-Alonso M, Muniesa MJ, Sanchez C. Pterygium surgery by means of conjunctival autograft: long term follow-up. Arq Bras Oftalmol. 2012;75(4):251–5.
  27. Chaidaroon W, Wattananikorn S. Conjunctival autograft transplantation for primary pterygium. J Med Assoc Thai. 2003;86(2):111–5.
  28. Kwon SH, Kim HK. Analysis of recurrence patterns following pterygium surgery with conjunctival autografts. Medicine (Baltimore). 2015;94(4):e518.
  29. Shehadeh-Mashor R, Srinivasan S, Boimer C, Lee K, Tomkins O, Slomovic AR. Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue. Am J Ophthalmol. 2011;152(5):730 –2.
  30. Huang X, Zhu B, Lin L, Jin X. Clinical results for combination of fibrin glue and nasal margin suture fixation for attaching conjunctival autografts after pterygium excision in Chinese pterygium patients. Medicine (Baltimore). 2018;97(44):e13050.
  31. Pan HW, Zhong JX, Jing CX. Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: a meta-analysis. Ophthalmology. 2011;118(6):1049 –54.
  32. Lan A, Xiao F, Wang Y, Luo Z, Cao Q. Efficacy of fibrin glue versus sutures for attaching conjunctival autografts in pterygium surgery: a systematic review with meta-analysis and trial sequential analysis of evidence. Oncotarget. 2017;8(25):41487 –97.

Background This study investigated the recurrence rates of primary pterygium following different surgical approaches, including conjunctival autografting alone, conjunctival autografting with intraoperative mitomycin C, and amniotic membrane grafting.  Methods In a retrospective cohort study of primary pterygium conducted from October 2022 to October 2024, 560 patients with an average age of 53.3 ± 14.1 years were included, with 94 cases undergoing surgery. Pterygium involving the cornea was present in 55% of cases. The overall recurrence rate for the three procedures was 17%, with an average time to recurrence of 14.2 ± 11.9 months, and 37% of recurrences occurred after the first year. Dry eye disease was the only significant risk factor for recurrence in both univariate (p = 0.021) and multivariate analysis (p = 0.026). The recurrence rates following conjunctival autografting with and without mitomycin C were 15.6% and 15.8%, respectively, while the rate following amniotic membrane grafting was twofold higher at 27% (OR= 2.02) compared to conjunctival autografting (15.8%).  Conclusions Dry eye disease was identified as the sole factor associated with pterygium recurrence in this study. The finding highlights the significance of extended post- operative monitoring, as over one-third of recurrences were detected after the first year. The slightly elevated recurrence rate following conjunctival grafting in our study, compared to existing literature, can be attributed to variances in study locations, demographics, and follow- up durations.

Keywords : Pterygium, Conjunctival, Amniotic.

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe